JH-RE-06 disrupts mutagenic translesion synthesis (TLS) by preventing the recruitment of mutagenic POLζ. JH-RE-06 is an effective REV1-REV7 interface inhibitor (IC50=0.78 μM; Kd=0.42 μM), which targets REV1 that interacts with the REV7 subunit of POLζ. JH-RE-06 also improves chemotherapy.
产品名:JH-RE-06
货号:orb1308178
产品中文名:JH-RE-06
产品详情链接:https://www.biorbyt.com.cn/jh-re-06-orb1308178.html 武汉博欧特生物科技有限公司(www.biorbyt.com.cn )为英国品牌Biorbyt(www.biorbyt.com )中国区总代理。负责biorbyt品牌产品在中国市场的推广、销售及售后服务。为您提供各种biorbyt原装进口产品,主推四大类: